Publications 2019

Thorgersen EB, Barratt-Due A, Haugaa H, Harboe M, Pischke SE, Nilsson PH, Mollnes TE (2019)
The Role of Complement in Liver Injury, Regeneration, and Transplantation
70 (2), 725-736
DOI 10.1002/hep.30508, PubMed 30653682

Publications 2017

Harboe M, Johnson C, Nymo S, Ekholt K, Schjalm C, Lindstad JK, Pharo A, Hellerud BC, Nilsson Ekdahl K, Mollnes TE, Nilsson PH (2017)
Properdin binding to complement activating surfaces depends on initial C3b deposition
114 (4), E534-E539
DOI 10.1073/pnas.1612385114, PubMed 28069958

Publications 2012

Harboe M, Garred P, Lindstad JK, Pharo A, Müller F, Stahl GL, Lambris JD, Mollnes TE (2012)
The role of properdin in zymosan- and Escherichia coli-induced complement activation
189 (5), 2606-13
DOI 10.4049/jimmunol.1200269, PubMed 22851705

Publications 2011

Harboe M, Thorgersen EB, Mollnes TE (2011)
Advances in assay of complement function and activation
63 (12), 976-87
DOI 10.1016/j.addr.2011.05.010, PubMed 21664392

Publications 2010

Wiker HG, Mustafa T, Bjune GA, Harboe M (2010)
Evidence for waning of latency in a cohort study of tuberculosis
10, 37
DOI 10.1186/1471-2334-10-37, PubMed 20178619

Publications 2009

Capra JD, Frøland SS, Harboe M, Jonsson R, Ljunggren HG, Wigzell H (2009)
Professor emeritus Jacob B. Natvig, one of the founders of Scandinavian journal of immunology, turns 75
70 (6), 503-4
DOI 10.1111/j.1365-3083.2009.02343.x, PubMed 19906190

Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE (2009)
Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis
69 (6), 479-91
DOI 10.1111/j.1365-3083.2009.02255.x, PubMed 19439008

Harboe M, Garred P, Karlstrøm E, Lindstad JK, Stahl GL, Mollnes TE (2009)
The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification
47 (2-3), 373-80
DOI 10.1016/j.molimm.2009.09.005, PubMed 19800125

Hellerud BC, Aase A, Herstad TK, Naess LM, Kristiansen LH, Trøseid AM, Harboe M, Lappegård KT, Brandtzaeg P, Høiby EA, Mollnes TE (2009)
Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies
78 (2), 802-9
DOI 10.1128/IAI.01044-09, PubMed 19933829

Lappegård KT, Christiansen D, Pharo A, Thorgersen EB, Hellerud BC, Lindstad J, Nielsen EW, Bergseth G, Fadnes D, Abrahamsen TG, Høiby EA, Schejbel L, Garred P, Lambris JD, Harboe M, Mollnes TE (2009)
Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature
106 (37), 15861-6
DOI 10.1073/pnas.0903613106, PubMed 19717455

Publications 2008

Harboe M, Mollnes TE (2008)
The alternative complement pathway revisited
12 (4), 1074-84
DOI 10.1111/j.1582-4934.2008.00350.x, PubMed 18419792

Norheim G, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Merid Y, Høiby EA, Caugant DA, Fritzsønn E, Tangen T, Melak B, Berhanu D, Harboe M, Kolberg J, Rosenqvist E (2008)
Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci
15 (5), 863-71
DOI 10.1128/CVI.00252-07, PubMed 18337382

Salvesen B, Nielsen EW, Harboe M, Saugstad OD, Mollnes TE (2008)
Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood
46 (4), 688-94
DOI 10.1016/j.molimm.2008.09.001, PubMed 18950866

Publications 2007

Harboe M (2007)
A new type in the Gm system - Commentary
APMIS, 115 (5), 556-557
DOI 10.1111/j.1600-0463.2007.apm_688.x

Norheim G, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Merid Y, Høiby EA, Caugant DA, Fritzsønn E, Tangen T, Alebel T, Berhanu D, Harboe M, Rosenqvist E (2007)
Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7
14 (4), 451-63
DOI 10.1128/CVI.00008-07, PubMed 17301215

Publications 2006

Harboe M (2006)
[This is not our medical ethic]
126 (17), 2283
PubMed 16967071

Harboe M (2006)
[The new face of tuberculosis in Norway]
126 (20), 2682-3
PubMed 17057770

Harboe M, Garred P, Borgen MS, Stahl GL, Roos A, Mollnes TE (2006)
Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions
144 (3), 512-20
DOI 10.1111/j.1365-2249.2006.03072.x, PubMed 16734621

Norheim G, Rosenqvist E, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Høiby EA, Alebel T, Berhanu D, Merid Y, Harboe M, Caugant DA (2006)
Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989
44 (3), 861-71
DOI 10.1128/JCM.44.3.861-871.2006, PubMed 16517868

Publications 2005

Harboe M, Aseffa A, Leekassa R (2005)
Challenges presented by nerve damage in leprosy
76 (1), 5-13
PubMed 15881032

Harboe M, Aseffa A, Leekassa R (2005)
Challenges presented by nerve damage in leprosy
Lepr. Rev., 76 (1), 5-13

Publications 2004

Abebe M, Lakew M, Kidane D, Lakew Z, Kiros K, Harboe M (2004)
Female genital tuberculosis in Ethiopia
84 (3), 241-6
DOI 10.1016/j.ijgo.2003.11.002, PubMed 15001372

Abebe M, Lakew M, Kidane D, Lakew Z, Kiros K, Harboe M (2004)
Female genital tuberculosis in Ethiopia
42 Suppl 1, 37-41
PubMed 16895018

Habte A, Geletu M, Olobo JO, Kidane D, Negesse Y, Yassin MA, Kifle B, Abate G, Harboe M, Aseff A (2004)
T cell mediated immune responses in patients with tuberculous lymphadenitis from Butajira, southern Ethiopia
42 Suppl 1, 29-35
PubMed 16895017

Harboe M, Das AK, Mitra D, Ulvund G, Ahmad S, Harkness RE, Das D, Mustafa AS, Wiker HG (2004)
Immunodominant B-cell epitope in the Mce1A mammalian cell entry protein of Mycobacterium tuberculosis cross-reacting with glutathione S-transferase
59 (2), 190-7
DOI 10.1111/j.0300-9475.2004.01383.x, PubMed 14871296

Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE (2004)
The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation
138 (3), 439-46
DOI 10.1111/j.1365-2249.2004.02627.x, PubMed 15544620

Publications 2003

Beyene D, Aseffa A, Harboe M, Kidane D, Macdonald M, Klatser PR, Bjune GA, Smith WC (2003)
Nasal carriage of Mycobacterium leprae DNA in healthy individuals in Lega Robi village, Ethiopia
131 (2), 841-8
DOI 10.1017/s0950268803001079, PubMed 14596524

Das AK, Mitra D, Harboe M, Nandi B, Harkness RE, Das D, Wiker HG (2003)
Predicted molecular structure of the mammalian cell entry protein Mce1A of Mycobacterium tuberculosis
302 (3), 442-7
DOI 10.1016/s0006-291x(03)00116-5, PubMed 12615052

Tollefsen S, Pollock JM, Lea T, Harboe M, Wiker HG (2003)
T- and B-cell epitopes in the secreted Mycobacterium bovis antigen MPB70 in mice
57 (2), 151-61
DOI 10.1046/j.1365-3083.2003.01211.x, PubMed 12588661

Yassin MA, Olobo JO, Kidane D, Negesse Y, Shimeles E, Tadesse A, Demissie A, Britton S, Harboe M, Aseffa A, Abate G (2003)
Diagnosis of tuberculous lymphadenitis in Butajira, rural Ethiopia
35 (4), 240-3
DOI 10.1080/00365540310004027, PubMed 12839151

Publications 2002

Harboe M, Christensen A, Ahmad S, Ulvund G, Harkness RE, Mustafa AS, Wiker HG (2002)
Cross-reaction between mammalian cell entry (Mce) proteins of Mycobacterium tuberculosis
56 (6), 580-7
DOI 10.1046/j.1365-3083.2002.01172.x, PubMed 12472669

Harboe M, Whelan AO, Ulvund G, McNair J, Pollock JM, Hewinson RG, Wiker HG (2002)
Generation of antibodies to the signal peptide of the MPT83 lipoprotein of Mycobacterium tuberculosis
55 (1), 82-7
DOI 10.1046/j.1365-3083.2002.01030.x, PubMed 11841695

Kidane D, Olobo JO, Habte A, Negesse Y, Aseffa A, Abate G, Yassin MA, Bereda K, Harboe M (2002)
Identification of the causative organism of tuberculous lymphadenitis in ethiopia by PCR
40 (11), 4230-4
DOI 10.1128/JCM.40.11.4230-4234.2002, PubMed 12409403

Tollefsen S, Tjelle T, Schneider J, Harboe M, Wiker H, Hewinson G, Huygen K, Mathiesen I (2002)
Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation
20 (27-28), 3370-8
DOI 10.1016/s0264-410x(02)00289-x, PubMed 12213407

Publications 2001

Harboe M (2001)
25th Kellersberger memorial lecture, 2000. The contribution of immunology to tuberculosis control
39 (1), 75-82
PubMed 11338470

Harboe M (2001)
[Immunology and control of tuberculosis]
121 (1), 88-91
PubMed 12013623

Harboe M (2001)
25(th) Kellersberger Memorial Lecture, 2000. The contribution of immunology to tuberculosis control
Ethiop. Med. J., 39 (1), 75-82

Johnson S, Brusasca P, Lyashchenko K, Spencer JS, Wiker HG, Bifani P, Shashkina E, Kreiswirth B, Harboe M, Schluger N, Gomez M, Gennaro ML (2001)
Characterization of the secreted MPT53 antigen of Mycobacterium tuberculosis
69 (9), 5936-9
DOI 10.1128/IAI.69.9.5936-5939.2001, PubMed 11500477

Lyashchenko KP, Wiker HG, Harboe M, McNair J, Komissarenko SV, Pollock JM (2001)
Novel monoclonal antibodies against major antigens of Mycobacterium bovis
53 (5), 498-502
DOI 10.1046/j.1365-3083.2001.00914.x, PubMed 11309158

Poléo ABS, Johannessen HF, Harboe M (2001)
High voltage direct current (HVDC) sea cables and sea electrodes: effects on marine life: 1st revision of the literature study
University of Oslo, Oslo, 50 s.
BIBSYS 070201072

Publications 2000

Harboe M (2000)
Leprosy at a turning point?
68 (3), 312-8
PubMed 11221095

Harboe M (2000)
Leprosy at a turning point?
Int. J. Lepr. Other Mycobact. Dis., 68 (3), 312-318

Harboe M (2000)
Robert N. Mshana, MD, Ph.D. 1954-2000 - Obituary
Int. J. Lepr. Other Mycobact. Dis., 68 (4), 475-476

Hernández-Pando R, Jeyanathan M, Mengistu G, Aguilar D, Orozco H, Harboe M, Rook GA, Bjune G (2000)
Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection
356 (9248), 2133-8
DOI 10.1016/s0140-6736(00)03493-0, PubMed 11191539

Iyer A, Mistry N, Antia N, Harboe M (2000)
Clarification to Rada-Schlaefli, et al
68 (1), 63-4
PubMed 10834071

Iyer A, Mistry N, Antia N, Harboe M (2000)
Clarification to Rada-Schlaefli, et al.
Int. J. Lepr. Other Mycobact. Dis., 68 (1), 63-64

Smith WC, Smith C, Cree I, Klatser P, Harboe M, Bjune G, Edward VK, MILEP2 Study Grp (2000)
Approaches to studying the transmission of Mycobacterium leprae
Lepr. Rev., 71 S, S26-S29

Publications 1999

Ahmad S, Akbar PK, Wiker HG, Harboe M, Mustafa AS (1999)
Cloning, expression and immunological reactivity of two mammalian cell entry proteins encoded by the mce1 operon of Mycobacterium tuberculosis
50 (5), 510-8
DOI 10.1046/j.1365-3083.1999.00631.x, PubMed 10564554

Ahmad S, Akbar PK, Wiker HG, Harboe M, Mustafa AS (1999)
Cloning, expression and immunological reactivity of two mammalian cell entry proteins encoded by the mce1 operon of Mycobacterium tuberculosis
Scand. J. Immunol., 50 (5), 510-518

Harboe M (1999)
Structure of the 15th International Leprosy Congress
Int. J. Lepr. Other Mycobact. Dis., 67 (1), 64-65

Harboe M, Christensen A, Haile Y, Ulvund G, Ahmad S, Mustafa AS, Wiker HG (1999)
Demonstration of expression of six proteins of the mammalian cell entry (mce1) operon of Mycobacterium tuberculosis by anti-peptide antibodies, enzyme-linked immunosorbent assay and reverse transcription-polymerase chain reaction
50 (5), 519-27
DOI 10.1046/j.1365-3083.1999.00632.x, PubMed 10564555

Harboe M, Christensen A, Haile Y, Ulvund G, Ahmad S, Mustafa AS, Wiker HG (1999)
Demonstration of expression of six proteins of the mammalian cell entry (mce1) operon of Mycobacterium tuberculosis by anti-peptide antibodies, enzyme-linked immunosorbent assay and reverse transcription-polymerase chain reaction
Scand. J. Immunol., 50 (5), 519-527

Harboe M, Wiker HG (1999)
Searching for secreted proteins of Mycobacterium leprae
71 (1), 19-35
PubMed 10439323

Wiker HG, Michell SL, Hewinson RG, Spierings E, Nagai S, Harboe M (1999)
Cloning, expression and significance of MPT53 for identification of secreted proteins of Mycobacterium tuberculosis
26 (4), 207-19
DOI 10.1006/mpat.1998.0267, PubMed 10089161

Wiker HG, Spierings E, Kolkman MA, Ottenhoff TH, Harboe M (1999)
The mammalian cell entry operon 1 (mce1) of mycobacterium leprae and mycobacterium tuberculosis
27 (3), 173-7
DOI 10.1006/mpat.1999.0298, PubMed 10455007

Publications 1998

Harboe M (1998)
Protective immunity to intracellular parasites--a focus for vaccine research and a challenge to immunization programmes
92, 145-7
PubMed 9554268

Harboe M (1998)
Protective immunity to intracellular parasites - A focus for vaccine research and a challenge to immunization programmes
Dev.Biol.Stand., 92, 145-147

Harboe M (1998)
Immunforsvaret hos eldre
In Medicinsk årbog, Norli, Oslo, 1998, s. 39-42
BIBSYS 050243713

Harboe M, Malin AS, Dockrell HS, Wiker HG, Ulvund G, Holm A, Jørgensen MC, Andersen P (1998)
B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis
66 (2), 717-23
DOI 10.1128/IAI.66.2.717-723.1998, PubMed 9453632

Harboe M, Wiker HG (1998)
Secreted proteins of Mycobacterium leprae
48 (6), 577-84
DOI 10.1046/j.1365-3083.1998.00451.x, PubMed 9874491

Harboe M, Wiker HG (1998)
Secreted proteins of Mycobacterium leprae
Scand. J. Immunol., 48 (6), 577-584

Harboe M, Wiker HG, Ulvund G, Lund-Pedersen B, Andersen AB, Hewinson RG, Nagai S (1998)
MPB70 and MPB83 as indicators of protein localization in mycobacterial cells
66 (1), 289-96
DOI 10.1128/IAI.66.1.289-296.1998, PubMed 9423870

Hetland G, Wiker HG, Høgåsen K, Hamasur B, Svenson SB, Harboe M (1998)
Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis
5 (2), 211-8
DOI 10.1128/CDLI.5.2.211-218.1998, PubMed 9521145

Jansen JH, Høgåsen K, Harboe M, Hovig T (1998)
In situ complement activation in porcine membranoproliferative glomerulonephritis type II
53 (2), 331-49
DOI 10.1046/j.1523-1755.1998.00765.x, PubMed 9461093

Natvig JB, Harboe M, Tonder O (1998)
Erik Waaler - in memoriam
Scand. J. Rheumatol., 27 (2), 89-90

Sethna KB, Mistry NF, Dholakia Y, Antia NH, Harboe M (1998)
Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients
30 (4), 363-9
DOI 10.1080/00365549850160657, PubMed 9817516

Sethna KB, Mistry NF, Dholakia Y, Antia NH, Harboe M (1998)
Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients
Scand. J. Infect. Dis., 30 (4), 363-369

Wiker HG, Lyashchenko KP, Aksoy AM, Lightbody KA, Pollock JM, Komissarenko SV, Bobrovnik SO, Kolesnikova IN, Mykhalsky LO, Gennaro ML, Harboe M (1998)
Immunochemical characterization of the MPB70/80 and MPB83 proteins of Mycobacterium bovis
66 (4), 1445-52
DOI 10.1128/IAI.66.4.1445-1452.1998, PubMed 9529066

Publications 1997

Høgåsen K, Jansen JH, Harboe M (1997)
Eradication of porcine factor H deficiency in Norway
140 (15), 392-5
DOI 10.1136/vr.140.15.392, PubMed 9141221

Moen O, Hogasen K, Fosse E, Dregelid E, Brockmeier V, Venge P, Harboe M, Mollnes TE (1997)
Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass
Ann. Thorac. Surg., 63 (1), 105-111

Moen O, Høgåsen K, Fosse E, Dregelid E, Brockmeier V, Venge P, Harboe M, Mollnes TE (1997)
Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass
63 (1), 105-11
DOI 10.1016/s0003-4975(96)00743-6, PubMed 8993250

Mollnes TE, Andreassen IH, Høgåsen K, Hack CE, Harboe M (1997)
Effect of whole and fractionated intravenous immunoglobulin on complement in vitro
34 (10), 719-29
DOI 10.1016/s0161-5890(97)00091-6, PubMed 9430199

Publications 1996

Harboe M (1996)
Helse og elektromagnetiske felt
In Medicinsk årbog, Norli, Oslo, 1996, s. 161-170
BIBSYS 042449499

Harboe M, Andersen P, Colston MJ, Gicquel B, Hermans PW, Ivanyi J, Kaufmann SH (1996)
European Commission COST/STD Initiative. Report of the expert panel IX. Vaccines against tuberculosis
14 (7), 701-16
DOI 10.1016/s0264-410x(96)90051-1, PubMed 8799982

Harboe M, Andersen P, Colston MJ, Gicquel B, Hermans PWM, Ivanyi J, Kaufmann SHE (1996)
European Commission COST/STD Initiative - Vaccines Against Tuberculosis
Vaccine, 14 (7), 701-716

Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P (1996)
Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG
64 (1), 16-22
DOI 10.1128/iai.64.1.16-22.1996, PubMed 8557334

Mistry NF, Iyer A, Harboe M, Antia NH (1996)
Low rates of detection of mycobacterial secretory antigen 85 in sera of untreated leprosy patients
64 (4), 451-3
PubMed 9030114

Mistry NF, Iyer A, Harboe M, Antia NH (1996)
Low rates of detection of mycobacterial secretory antigen 85 in sera of untreated leprosy patients
Int. J. Lepr. Other Mycobact. Dis., 64 (4), 451-453

Mollnes TE, Harboe M (1996)
Clinical immunology
312 (7044), 1465-9
DOI 10.1136/bmj.312.7044.1465, PubMed 8664630

Wiker HG, Nagai S, Hewinson RG, Russell WP, Harboe M (1996)
Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
43 (4), 374-80
DOI 10.1046/j.1365-3083.1996.d01-61.x, PubMed 8668915

Publications 1995

Harboe M (1995)
[Electromagnetic fields and health]
115 (20), 2522-3
PubMed 7676413

Harboe M (1995)
Taurin effluks fra isolerte rotteleverceller ved hyposmotiske betingelser
[M. Harboe], Oslo, 63 s.
BIBSYS 951762907

Harboe M, Nagai S, Wiker HG, Sletten K, Haga S (1995)
Homology between the MPB70 and MPB83 proteins of Mycobacterium bovis BCG
42 (1), 46-51
DOI 10.1111/j.1365-3083.1995.tb03624.x, PubMed 7631144

Hermans PW, Abebe F, Kuteyi VI, Kolk AH, Thole JE, Harboe M (1995)
Molecular and immunological characterization of the highly conserved antigen 84 from Mycobacterium tuberculosis and Mycobacterium leprae
63 (3), 954-60
DOI 10.1128/iai.63.3.954-960.1995, PubMed 7868268

HOGASEN K, MOLLNES TE, HARBOE M, GOTZE O, HAMMER HB, OPPERMANN M (1995)
TERMINAL COMPLEMENT PATHWAY ACTIVATION AND LOW LYSIS INHIBITORS IN RHEUMATOID-ARTHRITIS SYNOVIAL-FLUID
J. Rheumatol., 22 (1), 24-28

Høgåsen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M (1995)
Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency
95 (3), 1054-61
DOI 10.1172/JCI117751, PubMed 7883953

Høgåsen K, Mollnes TE, Harboe M, Götze O, Hammer HB, Oppermann M (1995)
Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid
22 (1), 24-8
PubMed 7535360

Mollnes TE, Høgåsen K, Hoaas BF, Michaelsen TE, Garred P, Harboe M (1995)
Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding properties
41 (5), 449-56
DOI 10.1111/j.1365-3083.1995.tb03591.x, PubMed 7725063

Mollnes TE, Riesenfeld J, Garred P, Nordström E, Høgåsen K, Fosse E, Götze O, Harboe M (1995)
A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin
19 (9), 909-17
DOI 10.1111/j.1525-1594.1995.tb02450.x, PubMed 8687297

Ostenstad B, Sioud M, Schlichting E, Lea T, Harboe M (1995)
Freshly isolated tumour-infiltrating T-lymphocytes have a high cytotoxic potential, as measured by their ability to induce apoptosis in the target cell
41 (1), 42-8
DOI 10.1111/j.1365-3083.1995.tb03531.x, PubMed 7824887

Ulstrup JC, Jeansson S, Wiker HG, Harboe M (1995)
Relationship of secretion pattern and MPB70 homology with osteoblast-specific factor 2 to osteitis following Mycobacterium bovis BCG vaccination
63 (2), 672-5
DOI 10.1128/iai.63.2.672-675.1995, PubMed 7822037

Wieles B, Nagai S, Wiker HG, Harboe M, Ottenhoff TH (1995)
Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis
63 (12), 4946-8
DOI 10.1128/iai.63.12.4946-4948.1995, PubMed 7591163

Publications 1994

Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A (1994)
Dual role of mannan-binding protein in infections: another case of heterosis?
21 (2), 125-31
DOI 10.1111/j.1744-313x.1994.tb00183.x, PubMed 9098426

Harboe M (1994)
Faglig utvalg til vurdering av mulig helsefare knyttet til lavfrekvente elektromagnetiske felt: redegjørelse for utvalgets arbeid og rapporten til Sosial- og helsedepartementet ved presseseminaret 18. mai 1994
Utvalget, Oslo, 6 s.
BIBSYS 000269239

Ostenstad B, Harboe M, Lea T (1994)
Differential effects of cyclic adenosine 3',5'-monophosphate on T cell cytotoxicity
24 (9), 2150-4
DOI 10.1002/eji.1830240932, PubMed 8088333

Ostenstad B, Lea T, Schlichting E, Harboe M (1994)
Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area
35 (3), 382-7
DOI 10.1136/gut.35.3.382, PubMed 8150352

Ostenstad B, Sioud M, Lea T, Schlichting E, Harboe M (1994)
Limited heterogeneity in the T-cell receptor V-gene usage in lymphocytes infiltrating human colorectal tumours
69 (6), 1078-82
DOI 10.1038/bjc.1994.211, PubMed 8198973

Wieles B, van Agterveld M, Janson A, Clark-Curtiss J, Rinke de Wit T, Harboe M, Thole J (1994)
Characterization of a Mycobacterium leprae antigen related to the secreted Mycobacterium tuberculosis protein MPT32
62 (1), 252-8
DOI 10.1128/iai.62.1.252-258.1994, PubMed 8262636

Publications 1993

Huygen K, Drowart A, Harboe M, ten Berg R, Cogniaux J, Van Vooren JP (1993)
Influence of genes from the major histocompatibility complex on the antibody repertoire against culture filtrate antigens in mice infected with live Mycobacterium bovis BCG
61 (6), 2687-93
DOI 10.1128/iai.61.6.2687-2693.1993, PubMed 8500908

Høgåsen K, Mollnes TE, Tschopp J, Harboe M (1993)
Quantitation of vitronectin and clusterin. Pitfalls and solutions in enzyme immunoassays for adhesive proteins
160 (1), 107-15
DOI 10.1016/0022-1759(93)90014-x, PubMed 7680696

Li H, Ulstrup JC, Jonassen TO, Melby K, Nagai S, Harboe M (1993)
Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG
61 (5), 1730-4
DOI 10.1128/iai.61.5.1730-1734.1993, PubMed 8478061

Osterland CK, Harboe M, Kunkel HG (1993)
Anti-gammaglobulin factors in human sera revealed by enzymatic splitting of anti-Rh antibodies. Vox Sang 1963;8:133-52
64 (4), 246-7
DOI 10.1111/j.1423-0410.1993.tb03065.x, PubMed 7685972

Rambukkana A, Burggraaf JD, Faber WR, Harboe M, Teeling P, Krieg S, Das PK (1993)
The mycobacterial secreted antigen 85 complex possesses epitopes that are differentially expressed in human leprosy lesions and Mycobacterium leprae-infected armadillo tissues
61 (5), 1835-45
DOI 10.1128/iai.61.5.1835-1845.1993, PubMed 7682995

Rambukkana A, Das PK, Kolk AH, Burggraaf JD, Kuijper S, Harboe M (1993)
Identification of a novel 27-kDa protein from Mycobacterium tuberculosis culture fluid by a monoclonal antibody specific for the Mycobacterium tuberculosis complex
37 (4), 471-8
DOI 10.1111/j.1365-3083.1993.tb03321.x, PubMed 8469931

Publications 1992

Harboe M (1992)
The significance of proteins actively secreted by Mycobacterium tuberculosis in relation to immunity and complications of mycobacterial diseases
60 (3), 470-6
PubMed 1474286

Harboe M (1992)
[Gerhard Henrik Armauer Hansen--still of current interest]
112 (30), 3795-8
PubMed 1485294

HARBOE M (1992)
THE SIGNIFICANCE OF PROTEINS ACTIVELY SECRETED BY MYCOBACTERIUM-TUBERCULOSIS IN RELATION TO IMMUNITY AND COMPLICATIONS OF MYCOBACTERIAL DISEASES
Int. J. Lepr. Other Mycobact. Dis., 60 (3), 470-476

Harboe M, Wiker HG (1992)
The 38-kDa protein of Mycobacterium tuberculosis: a review
166 (4), 874-84
DOI 10.1093/infdis/166.4.874, PubMed 1527425

Harboe M, Wiker HG, Nagai S (1992)
Protein antigens of mycobacteria studied by quantitative immunologic techniques
14 (1), 313-9
DOI 10.1093/clinids/14.1.313, PubMed 1571446

HOGASEN K, MOLLNES TE, HARBOE M (1992)
HEPARIN-BINDING PROPERTIES OF VITRONECTIN ARE LINKED TO COMPLEX-FORMATION AS ILLUSTRATED BY INVITRO POLYMERIZATION AND BINDING TO THE TERMINAL COMPLEMENT COMPLEX
J. Biol. Chem., 267 (32), 23076-23082

Høgåsen K, Mollnes TE, Harboe M (1992)
Heparin-binding properties of vitronectin are linked to complex formation as illustrated by in vitro polymerization and binding to the terminal complement complex
267 (32), 23076-82
PubMed 1385412

Rambukkana A, Das PK, Burggraaf JD, Faber WR, Teeling P, Krieg S, Thole JE, Harboe M (1992)
Identification and characterization of epitopes shared between the mycobacterial 65-kilodalton heat shock protein and the actively secreted antigen 85 complex: their in situ expression on the cell wall surface of Mycobacterium leprae
60 (11), 4517-27
DOI 10.1128/iai.60.11.4517-4527.1992, PubMed 1383151

Rambukkana A, Das PK, Burggraaf JD, Yong S, Faber WR, Thole JE, Harboe M (1992)
Heterogeneity of monoclonal antibody-reactive epitopes on mycobacterial 30-kilodalton-region proteins and the secreted antigen 85 complex and demonstration of antigen 85B on the Mycobacterium leprae cell wall surface
60 (12), 5172-81
DOI 10.1128/iai.60.12.5172-5181.1992, PubMed 1280626

Stavem P, Harboe M (1992)
Does graft-violates-host disease give a better indication of what goes on than graft-versus-host disease?
232 (4), 372
PubMed 1402643

STAVEM P, HARBOE M (1992)
DOES GRAFT-VIOLATES-HOST DISEASE GIVE A BETTER INDICATION OF WHAT GOES ON THAN GRAFT-VERSUS-HOST DISEASE
J. Intern. Med., 232 (4), 372

Wiker HG, Harboe M (1992)
The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis
56 (4), 648-61
DOI 10.1128/mr.56.4.648-661.1992, PubMed 1480113

WIKER HG, HARBOE M (1992)
THE ANTIGEN-85 COMPLEX - A MAJOR SECRETION PRODUCT OF MYCOBACTERIUM-TUBERCULOSIS
Microbiol. Rev., 56 (4), 648-661
DOI 10.1128/MMBR.56.4.648-661.1992

Wiker HG, Nagai S, Harboe M, Ljungqvist L (1992)
A family of cross-reacting proteins secreted by Mycobacterium tuberculosis
36 (2), 307-19
DOI 10.1111/j.1365-3083.1992.tb03104.x, PubMed 1502498

Publications 1991

Abou-Zeid C, Garbe T, Lathigra R, Wiker HG, Harboe M, Rook GA, Young DB (1991)
Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins
59 (8), 2712-8
DOI 10.1128/iai.59.8.2712-2718.1991, PubMed 1830294

Harboe M, Quayle AJ (1991)
Heat shock proteins: friend and foe?
86 (1), 2-5
DOI 10.1111/j.1365-2249.1991.tb05764.x, PubMed 1914233

HARBOE M, QUAYLE AJ (1991)
HEAT-SHOCK PROTEINS - FRIEND AND FOE
Clin. Exp. Immunol., 86 (1), 2-5

Jellum E, Harboe M, Bjune G, Wold S (1991)
Interpreting complicated chromatographic patterns
9 (8), 663-9
DOI 10.1016/0731-7085(91)80193-d, PubMed 1790187

Mollnes TE, Videm V, Götze O, Harboe M, Oppermann M (1991)
Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin
52 (1), 92-7
DOI 10.1016/0003-4975(91)91426-v, PubMed 2069469

Mollnes TE, Videm V, Riesenfeld J, Garred P, Svennevig JL, Fosse E, Hogasen K, Harboe M (1991)
Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials
86 Suppl 1 (Suppl 1), 21-6
PubMed 1934602

Nagai S, Wiker HG, Harboe M, Kinomoto M (1991)
Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis
59 (1), 372-82
DOI 10.1128/iai.59.1.372-382.1991, PubMed 1898899

Olmez U, Garred P, Mollnes TE, Harboe M, Berntzen HB, Munthe E (1991)
C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis
20 (3), 183-9
DOI 10.3109/03009749109103019, PubMed 2068540

OLMEZ U, GARRED P, MOLLNES TE, HARBOE M, BERNTZEN HB, MUNTHE E (1991)
C-3 ACTIVATION PRODUCTS, C-3 CONTAINING IMMUNE-COMPLEXES, THE TERMINAL COMPLEMENT COMPLEX AND NATIVE C-9 IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Scand. J. Rheumatol., 20 (3), 183-189

Salata RA, Sanson AJ, Malhotra IJ, Wiker HG, Harboe M, Phillips NB, Daniel TM (1991)
Purification and characterization of the 30,000 dalton native antigen of Mycobacterium tuberculosis and characterization of six monoclonal antibodies reactive with a major epitope of this antigen
118 (6), 589-98
PubMed 1720803

SALATA RA, SANSON AJ, MALHOTRA IJ, WIKER HG, HARBOE M, PHILLIPS NB, DANIEL TM (1991)
PURIFICATION AND CHARACTERIZATION OF THE 30,000 DALTON NATIVE ANTIGEN OF MYCOBACTERIUM-TUBERCULOSIS AND CHARACTERIZATION OF 6 MONOCLONAL-ANTIBODIES REACTIVE WITH A MAJOR EPITOPE OF THIS ANTIGEN
J. Lab. Clin. Med., 118 (6), 589-598

Wiker HG, Harboe M, Nagai S (1991)
A localization index for distinction between extracellular and intracellular antigens of Mycobacterium tuberculosis
137 (4), 875-84
DOI 10.1099/00221287-137-4-875, PubMed 1906925

Publications 1990

Garred P, Våge DI, Mollnes TE, Harboe M (1990)
Latex gloves as a cause of inflammation and eczema
335 (8703), 1469
DOI 10.1016/0140-6736(90)91502-2, PubMed 1972244

Harboe M, Natvig JB (1990)
Medisinsk immunologi
Stiftelsen medisinsk immunologi, Oslo (3. utg., rev.), 349 s.
BIBSYS 90078220x, ISBN 82-90225-04-0

Harboe M, Wiker HG, Duncan JR, Garcia MM, Dukes TW, Brooks BW, Turcotte C, Nagai S (1990)
Protein G-based enzyme-linked immunosorbent assay for anti-MPB70 antibodies in bovine tuberculosis
28 (5), 913-21
DOI 10.1128/jcm.28.5.913-921.1990, PubMed 2191012

Harboe M, Wiker HG, Lachmann PJ (1990)
Carrier effect of concanavalin A-reactive and -non-reactive material in tuberculin PPD
32 (3), 263-71
DOI 10.1111/j.1365-3083.1990.tb02919.x, PubMed 2402595

Wiker HG, Harboe M (1990)
Integration of monoclonal antibodies in quantitative immunoelectrophoresis by indirect immunoprecipitation
132 (1), 127-35
DOI 10.1016/0022-1759(90)90406-l, PubMed 2202762

Wiker HG, Harboe M, Nagai S, Bennedsen J (1990)
Quantitative and qualitative studies on the major extracellular antigen of Mycobacterium tuberculosis H37Rv and Mycobacterium bovis BCG
141 (4 Pt 1), 830-8
DOI 10.1164/ajrccm/141.4_Pt_1.830, PubMed 2109556

Wiker HG, Sletten K, Nagai S, Harboe M (1990)
Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex
58 (1), 272-4
DOI 10.1128/iai.58.1.272-274.1990, PubMed 2403534

Publications 1989

Fossum S, Harboe M, Thorsby E, Gundersen D (1989)
[Norwegian nomenclature in immunology]
109 (7-8), 853-5
PubMed 2705171

Publications 1988

Abou-Zeid C, Ratliff TL, Wiker HG, Harboe M, Bennedsen J, Rook GA (1988)
Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG
56 (12), 3046-51
DOI 10.1128/iai.56.12.3046-3051.1988, PubMed 3141278

FAT RFMLA, HARBOE M, JIN JCCP, DIESSELHOFFDENDULK MMC, VANFURTH R (1988)
INVITRO SYNTHESIS OF ANTIMYCOBACTERIAL ANTIBODIES WITH DIFFERENT SPECIFICITIES IN VARIOUS TISSUES OF LEPROSY PATIENTS
Int. J. Lepr. Other Mycobact. Dis., 56 (4), 552-558

Harboe M (1988)
Rheumatoid factors in leprosy and parasitic diseases
75, 309-13
DOI 10.3109/03009748809096783, PubMed 3070728

Lai A Fat RF, Harboe M, Chan Pin Jin JC, Diesselhoff-den Dulk MM, van Furth R (1988)
In vitro synthesis of antimycobacterial antibodies with different specificities in various tissues of leprosy patients
56 (4), 552-8
PubMed 3065420

Wiker HG, Harboe M, Bennedsen J, Closs O (1988)
The antigens of Mycobacterium tuberculosis, H37Rv, studied by crossed immunoelectrophoresis. Comparison with a reference system for Mycobacterium bovis, BCG
27 (2), 223-39
DOI 10.1111/j.1365-3083.1988.tb02342.x, PubMed 3124264

Publications 1987

Abou-Zeid C, Harboe M, Rook GA (1987)
Characterization of the secreted antigens of Mycobacterium bovis BCG: comparison of the 46-kilodalton dimeric protein with proteins MPB64 and MPB70
55 (12), 3213-4
DOI 10.1128/iai.55.12.3213-3214.1987, PubMed 3316036

De Bruyn J, Bosmans R, Turneer M, Weckx M, Nyabenda J, Van Vooren JP, Falmagne P, Wiker HG, Harboe M (1987)
Purification, partial characterization, and identification of a skin-reactive protein antigen of Mycobacterium bovis BCG
55 (1), 245-52
DOI 10.1128/iai.55.1.245-252.1987, PubMed 3539805

De Bruyn J, Huygen K, Bosmans R, Fauville M, Lippens R, Van Vooren JP, Falmagne P, Weckx M, Wiker HG, Harboe M (1987)
Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG
2 (5), 351-66
DOI 10.1016/0882-4010(87)90077-5, PubMed 3148811

Harboe M, Ivanyi J (1987)
Analysis of monoclonal antibodies to Mycobacterium leprae by crossed immunoelectrophoresis
25 (2), 133-8
DOI 10.1111/j.1365-3083.1987.tb01056.x, PubMed 3547616

Harboe M, Natvig JB (1987)
Medisinsk immunologi
Stiftelsen medisinsk immunologi, Oslo (3. utg.), 347 s.
BIBSYS 875020003, ISBN 87-7437-085-5

Menzel S, Harboe M, Bergsvik H, Brennan PJ (1987)
Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy
55 (4), 617-25
PubMed 3323365

MENZEL S, HARBOE M, BERGSVIK H, BRENNAN PJ (1987)
ANTIBODIES TO A SYNTHETIC ANALOG OF PHENOLIC GLYCOLIPID-I OF MYCOBACTERIUM-LEPRAE IN HEALTHY HOUSEHOLD CONTACTS OF PATIENTS WITH LEPROSY
Int. J. Lepr. Other Mycobact. Dis., 55 (4), 617-625

Mollnes TE, Harboe M (1987)
Immunohistochemical detection of the membrane and fluid-phase terminal complement complexes C5b-9(m) and SC5b-9. Consequences for interpretation and terminology
26 (4), 381-6
DOI 10.1111/j.1365-3083.1987.tb02270.x, PubMed 3685888

Wiker HG, Harboe M (1987)
Comparison of antigens and antisera in crossed immunoelectrophoresis by dual dilution
97 (2), 201-7
DOI 10.1016/0022-1759(87)90460-1, PubMed 3102615

Publications 1986

Gill HK, Mustafa AS, Ivanyi J, Harboe M, Godal T (1986)
Humoral immune responses to M. leprae in human volunteers vaccinated with killed, armadillo-derived M. leprae
57 Suppl 2, 293-300
PubMed 3553802

Harboe M (1986)
Functions of an external medical advisory committee
57 Suppl 1, 41-6
PubMed 3586834

Harboe M (1986)
Functions of an external medical advisory committee
24 Suppl 1, 41-6
PubMed 3608999

Harboe M, Nagai S, Patarroyo ME, Torres ML, Ramirez C, Cruz N (1986)
Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG
52 (1), 293-302
DOI 10.1128/iai.52.1.293-302.1986, PubMed 3514457

Harboe M, Wiker HG (1986)
Immunological and biochemical characterization and classification of mycobacterial antigens
57 Suppl 2, 33-7
DOI 10.5935/0305-7518.19860052, PubMed 3573945

Mollnes TE, Lea T, Mellbye OJ, Pahle J, Grand O, Harboe M (1986)
Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex
29 (6), 715-21
DOI 10.1002/art.1780290603, PubMed 3718564

Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M (1986)
Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro
65 (1), 73-9
PubMed 3641694

MOLLNES TE, NG YC, PETERS DK, LEA T, TSCHOPP J, HARBOE M (1986)
EFFECT OF NEPHRITIC FACTOR ON C-3 AND ON THE TERMINAL PATHWAY OF COMPLEMENT INVIVO AND INVITRO
Clin. Exp. Immunol., 65 (1), 73-79

Nagai S, Miura K, Tokunaga T, Harboe M (1986)
MPB70, a unique antigenic protein isolated from the culture filtrate of BCG substrain Tokyo
58 ( Pt B), 511-6
PubMed 3301461

OLCEN P, HARBOE M, VANDIEPEN TW (1986)
ANTIGENS OF MYCOBACTERIUM-LEPRAE IN URINE DURING TREATMENT OF PATIENTS WITH LEPROMATOUS LEPROSY
Lepr. Rev., 57 (4), 329-340

Olcén P, Harboe M, Warndorff van Diepen T (1986)
Antigens of Mycobacterium leprae in urine during treatment of patients with lepromatous leprosy
57 (4), 329-40
PubMed 3540495

Wiker HG, Harboe M, Lea TE (1986)
Purification and characterization of two protein antigens from the heterogeneous BCG85 complex in Mycobacterium bovis BCG
81 (4), 298-306
DOI 10.1159/000234153, PubMed 3536755

Wiker HG, Harboe M, Nagai S, Patarroyo ME, Ramirez C, Cruz N (1986)
MPB59, a widely cross-reacting protein of Mycobacterium bovis BCG
81 (4), 307-14
DOI 10.1159/000234154, PubMed 3536756

Publications 1985

Abou-Zeid C, Harboe M, Sundsten B, Cocito C (1985)
Cross-reactivity of antigens from the cytoplasm and cell walls of some corynebacteria and mycobacteria
151 (1), 170-8
DOI 10.1093/infdis/151.1.170, PubMed 3965589

Fosse E, Svennevig JL, Harboe M (1985)
Cell markers in stored blood
16 (6), 393-7
DOI 10.1016/0020-1383(85)90054-3, PubMed 4008032

Harboe M, Coates AR, Hewitt J (1985)
Characterization of the specificity of monoclonal antibodies against Mycobacterium tuberculosis by crossed immunoelectrophoresis
22 (1), 93-8
DOI 10.1111/j.1365-3083.1985.tb01863.x, PubMed 3927476

MEYERS WM, WALSH GP, BROWN HL, BINFORD CH, IMES GD, HADFIELD TL, SCHLAGEL CJ, FUKUNISHI Y, GERONE PJ, WOLF RH, GORMUS BJ, MARTIN LN, HARBOE M, IMAEDA T (1985)
LEPROSY IN A MANGABEY MONKEY NATURALLY ACQUIRED INFECTION
Int. J. Lepr. Other Mycobact. Dis., 53 (1), 1-14

Mollnes TE, Frøland SS, Harboe M (1985)
Increased plasma levels of the terminal complement complex in patients with evidence of complement activation
2 (2-3), 175-84
DOI 10.1159/000467858, PubMed 3878765

Mollnes TE, Lea T, Frøland SS, Harboe M (1985)
Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex
22 (2), 197-202
DOI 10.1111/j.1365-3083.1985.tb01871.x, PubMed 2412280

Mollnes TE, Lea T, Harboe M, Tschopp J (1985)
Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma
22 (2), 183-95
DOI 10.1111/j.1365-3083.1985.tb01870.x, PubMed 4035298

Reitan LJ, Closs O, Harboe M (1985)
Characterization of the immune response to an epitope on Mycobacterium leprae antigen 7 defined by a monoclonal antibody
22 (6), 711-20
DOI 10.1111/j.1365-3083.1985.tb01934.x, PubMed 2418496

Publications 1984

Harboe M, Nagai S (1984)
MPB70, a unique antigen of Mycobacterium bovis BCG
129 (3), 444-52
DOI 10.1164/arrd.1984.129.3.444, PubMed 6367574

HARBOE M, NAGAI S (1984)
MPB70, A UNIQUE ANTIGEN OF MYCOBACTERIUM-BOVIS BCG
Am. Rev. Respir. Dis., 129 (3), 444-452

Harboe M, Natvig JB (1984)
Medisinsk immunologi
Stiftelsen medisinsk immunologi, Oslo (2. rev. utg.), 322 s.
BIBSYS 842153586, ISBN 82-90225-02-4

Martin LN, Gormus BJ, Wolf RH, Walsh GP, Meyers WM, Binford CH, Harboe M (1984)
Experimental leprosy in nonhuman primates
28, 201-36
DOI 10.1016/b978-0-12-039228-5.50012-7, PubMed 6441464

MARTIN LN, GORMUS BJ, WOLF RH, WALSH GP, MEYERS WM, BINFORD CH, HARBOE M (1984)
EXPERIMENTAL LEPROSY IN NONHUMAN-PRIMATES
Adv. Vet. Sci. Comp. Med., 28, 201-236

Mollnes TE, Lea T, Harboe M (1984)
Detection and quantification of the terminal C5b-9 complex of human complement by a sensitive enzyme-linked immunosorbent assay
20 (2), 157-66
DOI 10.1111/j.1365-3083.1984.tb00989.x, PubMed 6474098

Olcén P, Harboe M, Warndorff T, Belehu A (1984)
Anti-Mycobacterium leprae antibodies in urine from lepromatous patients examined by crossed immunoelectrophoresis and radioimmunoassay
19 (6), 521-8
DOI 10.1111/j.1365-3083.1984.tb00963.x, PubMed 6377478

Rao AS, Liao J, Kabat EA, Osserman EF, Harboe M, Nimmich W (1984)
Immunochemical studies on human monoclonal macroglobulins with specificities for 3,4-pyruvylated D-galactose and 4,6-pyruvylated D-glucose
259 (2), 1018-26
PubMed 6693372

RAO AS, LIAO J, KABAT EA, OSSERMAN EF, HARBOE M, NIMMICH W (1984)
IMMUNOCHEMICAL STUDIES ON HUMAN MONOCLONAL MACROGLOBULINS WITH SPECIFICITIES FOR 3,4-PYRUVYLATED D-GALACTOSE AND 4,6-PYRUVYLATED D-GLUCOSE
J. Biol. Chem., 259 (2), 1018-1026

Publications 1983

Dahle JS, van Diepen TW, Touw Langendijk EJ, Harboe M, Belehu A (1983)
Effect of treatment on antibody activity against Mycobacterium leprae antigen 7 in tuberculoid leprosy
51 (3), 312-20
PubMed 6358062

DAHLE JS, VANDIEPEN TW, LANGENDIJK EJMT, HARBOE M, BELEHU A (1983)
EFFECT OF TREATMENT ON ANTIBODY-ACTIVITY AGAINST MYCOBACTERIUM-LEPRAE ANTIGEN-7 IN TUBERCULOID LEPROSY
Int. J. Lepr. Other Mycobact. Dis., 51 (3), 312-320

Gueur MC, Harboe M, Fontaine F, Delville J, Cocito C (1983)
Comparison of the cytoplasmic antigens of leprosy-derived corynebacteria and some mycobacteria
17 (6), 497-506
DOI 10.1111/j.1365-3083.1983.tb00817.x, PubMed 6191381

Harboe M (1983)
The work and concepts of Armauer Hansen: how do they stand today?
21 (2), 123-6
PubMed 6343074

HARBOE M (1983)
THE WORK AND CONCEPTS OF HANSEN,ARMAUER - HOW DO THEY STAND TODAY
Ethiop. Med. J., 21 (2), 123-126

LANGENDIJK EJMT, VANDIEPEN TW, HARBOE M, BELEHU A (1983)
RELATION BETWEEN ANTI-MYCOBACTERIUM-LEPRAE ANTIBODY-ACTIVITY AND CLINICAL-FEATURES IN BORDERLINE TUBERCULOID (BT) LEPROSY
Int. J. Lepr. Other Mycobact. Dis., 51 (3), 305-311

Mshana RN, Harboe M, Stoner GL, Hughes RA, Kadlubowski M, Belehu A (1983)
Immune responses to bovine neural antigens in leprosy patients. I. Absence of antibodies to an isolated myelin protein
51 (1), 33-40
PubMed 6190769

MSHANA RN, HARBOE M, STONER GL, HUGHES RAC, KADLUBOWSKI M, BELEHU A (1983)
IMMUNE-RESPONSES TO BOVINE NEURAL ANTIGENS IN LEPROSY PATIENTS .1. ABSENCE OF ANTIBODIES TO AN ISOLATED MYELIN PROTEIN
Int. J. Lepr. Other Mycobact. Dis., 51 (1), 33-40

Mshana RN, Humber DP, Belehu A, Harboe M (1983)
Immunohistological studies of skin biopsies from patients with lepromatous leprosy
3 (1), 22-9
DOI 10.1007/BF00919135, PubMed 6338025

Mshana RN, Humber DP, Harboe M, Belehu A (1983)
Immune responses to bovine neural antigens in leprosy patients. II. Absence of in vitro lymphocyte stimulation to peripheral nerve myelin proteins
54 (3), 217-27
DOI 10.5935/0305-7518.19830029, PubMed 6195500

Mshana RN, Humber DP, Harboe M, Belehu A (1983)
Nerve damage following intraneural injection of Mycobacterium leprae into rabbits pre-sensitized to mycobacteria
52 (2), 441-8
PubMed 6345041

Mshana RN, Humber DP, Harboe M, Belehu A (1983)
Demonstration of mycobacterial antigens in nerve biopsies from leprosy patients using peroxidase-antiperoxidase immunoenzyme technique
29 (3), 359-68
DOI 10.1016/0090-1229(83)90039-9, PubMed 6416726

MSHANA RN, HUMBER DP, HARBOE M, BELEHU A (1983)
NERVE DAMAGE FOLLOWING INTRANEURAL INJECTION OF MYCOBACTERIUM-LEPRAE INTO RABBITS PRESENSITIZED TO MYCOBACTERIA
Clin. Exp. Immunol., 52 (2), 441-448

MSHANA RN, HUMBER DP, HARBOE M, BELEHU A (1983)
IMMUNE-RESPONSES TO BOVINE NEURAL ANTIGENS IN LEPROSY PATIENTS .2. ABSENCE OF INVITRO LYMPHOCYTE STIMULATION TO PERIPHERAL-NERVE MYELIN PROTEINS
Lepr. Rev., 54 (3), 217-227

Olcén P, Harboe M, Warndorff T, Belehu A (1983)
Antigens of Mycobacterium leprae and anti-M. leprae antibodies in the urine of leprosy patients
54 (3), 203-16
DOI 10.5935/0305-7518.19830028, PubMed 6355725

OLCEN P, HARBOE M, WARNDORFF T, BELEHU A (1983)
ANTIGENS OF MYCOBACTERIUM-LEPRAE AND ANTI-MYCOBACTERIUM-LEPRAE ANTIBODIES IN THE URINE OF LEPROSY PATIENTS
Lepr. Rev., 54 (3), 203-216

Touw Langendijk EJ, van Diepen TW, Harboe M, Belehu A (1983)
Relation between anti-Mycobacterium leprae antibody activity and clinical features in borderline tuberculoid (BT) leprosy
51 (3), 305-11
PubMed 6358061

Publications 1982

Andersen O, Jantzen E, Closs O, Harboe M, Saxegaard F, Fodstad F (1982)
Fatty acid and polar lipid analysis as tools in the identification of Mycobacterium leprae and some related slow-growing mycobacterial species
133 (1), 29-37
PubMed 7051927

ANDERSEN O, JANTZEN E, CLOSS O, HARBOE M, SAXEGAARD F, FODSTAD F (1982)
FATTY-ACID AND POLAR LIPID ANALYSIS AS TOOLS IN THE IDENTIFICATION OF MYCOBACTERIUM-LEPRAE AND SOME RELATED SLOW-GROWING MYCOBACTERIAL SPECIES
ANN INST PASTEUR MIC, B133 (1), 29-37

Closs O, Reitan LJ, Negassi K, Harboe M, Belehu A (1982)
In vitro stimulation of lymphocytes in leprosy patients, healthy contacts of leprosy patients, and subjects not exposed to leprosy. Comparison of an antigen fraction prepared from Mycobacterium leprae and tuberculin-purified protein derivative
16 (2), 103-15
DOI 10.1111/j.1365-3083.1982.tb00704.x, PubMed 6182610

Harboe M (1982)
Significance of antibody studies in leprosy and experimental models of the disease
50 (3), 342-50
PubMed 6754640

HARBOE M (1982)
SIGNIFICANCE OF ANTIBODY STUDIES IN LEPROSY AND EXPERIMENTAL-MODELS OF THE DISEASE
Int. J. Lepr. Other Mycobact. Dis., 50 (3), 342-350

Harboe M, Natvig JB (1982)
Medisinsk immunologi
Stiftelsen medisinsk immunologi, [Oslo] (2. utg.), 311 s.
BIBSYS 835001067, ISBN 82-90225-01-6

Melsom R, Harboe M, Duncan ME (1982)
IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life
49 (3), 532-42
PubMed 6756719

MELSOM R, HARBOE M, DUNCAN ME (1982)
IGA, IGM AND IGG ANTI-M-LEPRAE ANTIBODIES IN BABIES OF LEPROSY MOTHERS DURING THE 1ST 2 YEARS OF LIFE
Clin. Exp. Immunol., 49 (3), 532-542

Melsom R, Harboe M, Myrvang B, Godal T, Belehu A (1982)
Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy
47 (2), 225-33
PubMed 7042137

MELSOM R, HARBOE M, MYRVANG B, GODAL T, BELEHU A (1982)
IMMUNOGLOBULIN CLASS SPECIFIC ANTIBODIES TO M- LEPRAE IN LEPROSY PATIENTS, INCLUDING THE INDETERMINATE GROUP AND HEALTHY CONTACTS AS A STEP IN THE DEVELOPMENT OF METHODS FOR SERO-DIAGNOSIS OF LEPROSY
Clin. Exp. Immunol., 47 (2), 225-233

Melsom R, Harboe M, Naafs B (1982)
Class specific anti-Mycobacterium leprae antibody assay in lepromatous leprosy (BL-LL) patients during the first two to four years of DDS treatment
50 (3), 271-81
PubMed 6754639

MELSOM R, HARBOE M, NAAFS B (1982)
CLASS SPECIFIC ANTI-MYCOBACTERIUM LEPRAE ANTIBODY-ASSAY IN LEPROMATOUS LEPROSY (BL-LL) PATIENTS DURING THE 1ST 2 TO 4 YEARS OF DDS TREATMENT
Int. J. Lepr. Other Mycobact. Dis., 50 (3), 271-281

Mshana RN, Belehu A, Stoner GL, Harboe M, Haregewoin A (1982)
Demonstration of mycobacterial antigens in leprosy tissues
50 (1), 1-10
PubMed 7042609

MSHANA RN, BELEHU A, STONER GL, HARBOE M, HAREGEWOIN A (1982)
DEMONSTRATION OF MYCOBACTERIAL ANTIGENS IN LEPROSY TISSUES
Int. J. Lepr. Other Mycobact. Dis., 50 (1), 1-10

Mshana RN, Haregewoin A, Harboe M, Belehu A (1982)
Thymus dependent lymphocytes in leprosy. I. T lymphocyte subpopulations defined by monoclonal antibodies
50 (3), 291-6
PubMed 6216220

MSHANA RN, HAREGEWOIN A, HARBOE M, BELEHU A (1982)
THYMUS DEPENDENT LYMPHOCYTES IN LEPROSY .1. LYMPHOCYTE-T SUB-POPULATIONS DEFINED BY MONOCLONAL-ANTIBODIES
Int. J. Lepr. Other Mycobact. Dis., 50 (3), 291-296

Publications 1981

Harboe M (1981)
Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis
124 (1), 80-7
DOI 10.1164/arrd.1981.124.1.80, PubMed 7020505

Harboe M (1981)
Mycobacterium leprae and the host response
52 Suppl 1, 1-14
PubMed 7040872

Harboe M (1981)
Radioimmunoassay and other serologic tests and their application in epidemiological work
52 Suppl 1, 275-88
DOI 10.5935/0305-7518.19810077, PubMed 7040881

HARBOE M (1981)
ANTIGENS OF PPD, OLD TUBERCULIN, AND AUTOCLAVED MYCOBACTERIUM-BOVIS BCG STUDIED BY CROSSED IMMUNOELECTROPHORESIS
Am. Rev. Respir. Dis., 124 (1), 80-87

HARBOE M (1981)
MYCOBACTERIUM-LEPRAE AND THE HOST RESPONSE
Lepr. Rev., 52 1, 1-14

HARBOE M (1981)
RADIOIMMUNOASSAY AND OTHER SEROLOGIC TESTS AND THEIR APPLICATION IN EPIDEMIOLOGICAL WORK
Lepr. Rev., 52 1, 275-288

Harboe M, Closs O (1981)
A claim for a Mycobacterium leprae specific antigen
49 (1), 85-9
PubMed 6788723

HARBOE M, CLOSS O (1981)
A CLAIM FOR A MYCOBACTERIUM-LEPRAE SPECIFIC ANTIGEN
Int. J. Lepr. Other Mycobact. Dis., 49 (1), 86-88

Harboe M, Closs O, Reitan LJ, Draper P (1981)
Demonstration of antibodies reacting with different determinants on Mycobacterium leprae antigen 7
49 (2), 147-58
PubMed 6168595

HARBOE M, CLOSS O, REITAN LJ, DRAPER P (1981)
DEMONSTRATION OF ANTIBODIES REACTING WITH DIFFERENT DETERMINANTS ON MYCOBACTERIUM-LEPRAE ANTIGEN-7
Int. J. Lepr. Other Mycobact. Dis., 49 (2), 147-158

Melsom R, Harboe M, Duncan ME, Bergsvik H (1981)
IgA and IgM antibodies against Mycobacterium leprae in cord sera and in patients with leprosy: an indicator of intrauterine infection in leprosy
14 (4), 343-52
DOI 10.1111/j.1365-3083.1981.tb00574.x, PubMed 7038849

Publications 1980

Closs O, Harboe M, Axelsen NH, Bunch-Christensen K, Magnusson M (1980)
The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system
12 (3), 249-63
DOI 10.1111/j.1365-3083.1980.tb00065.x, PubMed 7008186

Dworsky E, Sletten K, Harboe M, Wetteland P (1980)
Structural studies of three IgG kappa proteins from a patient with multiple myeloma
12 (4), 281-7
DOI 10.1111/j.1365-3083.1980.tb00068.x, PubMed 6781064

Harboe M (1980)
Immunological aspects of leprosy: ten years' activity at the Armauer Hansen Research Institute and Prospects for further work
48 (2), 193-205
PubMed 6156919

Harboe M (1980)
Anders Jahre's medical prizes for 1980 (Björn Folkow, Fredrik Kiil, Jens F Rehfeld, Lars Terenius)
30 (11-12), 137-43
PubMed 7012283

Lai A Fat RF, Chan Pin Jin J, van Furth R, Harboe M (1980)
In vitro synthesis of anti-mycobacterial antibodies in biopsies from skin lesions of leprosy patients
27 (2), 297-301
DOI 10.1128/iai.27.2.297-301.1980, PubMed 6991410

Melsom R, Duncan ME, Harboe M, Bjune G (1980)
Antibodies against Mycobacterium leprae antigen 7 from birth to 18 months of age: an indicator of intra-uterine infection in leprosy
42 (1), 107-13
PubMed 7006873

MELSOM R, DUNCAN ME, HARBOE M, BJUNE G (1980)
ANTIBODIES AGAINST MYCOBACTERIUM-LEPRAE ANTIGEN-7 FROM BIRTH TO 18 MONTHS OF AGE - AN INDICATOR OF INTRAUTERINE INFECTION IN LEPROSY
Clin. Exp. Immunol., 42 (1), 107-113

WIDEBACK K, KRONVALL G, BJORVATN B, CLOSS O, HARBOE M (1980)
COMPARATIVE STUDIES OF ANTIGEN-21 IN MYCOBACTERIUM AND NOCARDIA SPECIES - POSSIBLE TAXONOMIC RELATIONSHIPS WITH MYCOBACTERIUM-LEPRAE
Infect. Immun., 30 (2), 413-420

Widebäck K, Kronvall G, Bjorvatn B, Closs O, Harboe M (1980)
Comparative studies of antigen 21 in Mycobacterium and Nocardia species: possible taxonomic relationships with Mycobacterium leprae
30 (2), 413-20
DOI 10.1128/iai.30.2.413-420.1980, PubMed 7002798

Publications 1979

Closs O, Mshana RN, Harboe M (1979)
Antigenic analysis of Mycobacterium leprae
9 (3), 297-302
DOI 10.1111/j.1365-3083.1979.tb02735.x, PubMed 373076

Fagreus A, Harboe M, Natvig JB (1979)
Albert Coons, 1912--78
9 (5), 395-6
DOI 10.1111/j.1365-3083.1979.tb03179.x, PubMed 379980

Harboe M (1979)
[Nil nocere]
99 (1), 2-3
PubMed 760236

Harboe M, Mshana RN, Closs O, Kronvall G, Axelsen NH (1979)
Cross-reactions between mycobacteria. II. Crossed immunoelectrophoretic analysis of soluble antigens of BCG and comparison with other mycobacteria
9 (2), 115-24
DOI 10.1111/j.1365-3083.1979.tb02713.x, PubMed 106465

Mshana RN, Closs O, Harboe M (1979)
Antibody response in rabbits to Mycobacterium bovis BCG
9 (2), 175-82
DOI 10.1111/j.1365-3083.1979.tb02720.x, PubMed 370972

Negassi K, Closs O, Harboe M (1979)
Cross-reactions between serum proteins and water soluble liver tissue antigens of the nine-banded armadillo (Dasypus novemcinctus Linn.) and man
38 (1), 135-47
PubMed 93527

NEGASSI K, CLOSS O, HARBOE M (1979)
CROSS-REACTIONS BETWEEN SERUM-PROTEINS AND WATER-SOLUBLE LIVER-TISSUE ANTIGENS OF THE 9-BANDED ARMADILLO (DASYPUS-NOVEMCINCTUS LINN) AND MAN
Clin. Exp. Immunol., 38 (1), 135-147

Yoder L, Naafs B, Harboe M, Bjune G (1979)
Antibody activity against Mycobacterium leprae antigen 7 in leprosy: studies on variation in antibody content throughout the spectrum and on the effect of DDS treatment and relapse in BT leprosy
50 (2), 113-21
DOI 10.5935/0305-7518.19790017, PubMed 396427

YODER L, NAAFS B, HARBOE M, BJUNE G (1979)
ANTIBODY-ACTIVITY AGAINST MYCOBACTERIUM-LEPRAE ANTIGEN-7 IN LEPROSY - STUDIES ON VARIATION IN ANTIBODY CONTENT THROUGHOUT THE SPECTRUM AND ON THE EFFECT OF DDS TREATMENT AND RELAPSE IN BT-LEPROSY
Lepr. Rev., 50 (2), 113-121

Publications 1978

Harboe M, Closs O, Bjune G, Kronvall G, Axelsen NH (1978)
Mycobacterium leprae specific antibodies detected by radioimmunoassay
7 (2), 111-20
DOI 10.1111/j.1365-3083.1978.tb00433.x, PubMed 77549

Harboe M, Closs O, Rees RJ, Walsh GP (1978)
Formation of antibody against Mycobacterium leprae antigen 7 in armadillos
11 (4), 525-35
DOI 10.1099/00222615-11-4-525, PubMed 364069

Melsom R, Naafs B, Harboe M, Closs O (1978)
Antibody activity against Mycobacterium leprae antigen 7 during the first year of DDS treatment in lepromatous (BL-LL) leprosy
49 (1), 17-29
PubMed 347205

MELSOM R, NAAFS B, HARBOE M, CLOSS O (1978)
ANTIBODY ACTIVITY AGAINST MYCOBACTERIUM-LEPRAE ANTIGEN-7 DURING 1ST YEAR OF DDS TREATMENT IN LEPROMATOUS (BL-LL) LEPROSY
Lepr. Rev., 49 (1), 17-29

Negassi K, Closs O, Harboe M (1978)
False spurs in quantitative immunoelectrophoresis
8 (4), 279-90
DOI 10.1111/j.1365-3083.1978.tb00521.x, PubMed 82271

Svennevig JL, Closs O, Harboe M, Svaar H (1978)
Characterization of lymphocytes isolated from non-lymphoid human malignant tumours
7 (6), 487-93
DOI 10.1111/j.1365-3083.1978.tb00482.x, PubMed 356179

Publications 1977

Harboe M, Closs O, Bjorvatn B, Bjune G (1977)
Antibodies against BCG antigen 60 in mycobacterial infection
2 (6084), 430-3
DOI 10.1136/bmj.2.6084.430, PubMed 407965

Harboe M, Closs O, Bjorvatn B, Kronvall G, Axelsen NH (1977)
Antibody response in rabbits to immunization with Mycobacterium leprae
18 (3), 792-805
DOI 10.1128/iai.18.3.792-805.1977, PubMed 338491

Harboe M, Closs O, Svindahl K, Deverill J (1977)
Production and assay of antibodies against one antigenic component of Mycobacterium bovis BCG
16 (2), 662-72
DOI 10.1128/iai.16.2.662-672.1977, PubMed 324917

Publications 1976

AXELSEN NH, HARBOE M, JONSSON V, VIDEBAEK A (1976)
MU-CHAIN DISEASE IN A CASE OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MALIGNANT HISTIOCYTOMA .2. IMMUNOCHEMICAL STUDIES
SCAND J HAEMATOL, 16 (3), 218-225

Axelsen NH, Harboe M, Jonsson V, Videbaek AA (1976)
Mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. II. Immunochemical studies
16 (3), 218-25
DOI 10.1111/j.1600-0609.1976.tb01141.x, PubMed 179131

Harboe M (1976)
Importance of immune reactions in leprosy
14 (4), 205-12
PubMed 799966

Harboe M, Closs O, Deverill J (1976)
Production of monospecific antisera against antigenic componentsof Mycobacterium bovis (BCG)
5 (6-7), 861-6
DOI 10.1111/j.1365-3083.1976.tb03035.x, PubMed 790542

Harboe M, Folling I (1976)
Sudden death caused by interaction between a macroglobulin and a divalent drug
2 (7980), 285-9
DOI 10.1016/s0140-6736(76)90734-0, PubMed 59856

HARBOE M, FOLLING I, HAUGEN OA, BAUER K (1976)
SUDDEN-DEATH CAUSED BY INTERACTION BETWEEN A MACROGLOBULIN AND A DIVALENT DRUG
Lancet, 2 (7980), 285-288

JONSSON V, VIDEBAEK A, AXELSEN NH, HARBOE M (1976)
MU-CHAIN DISEASE IN A CASE OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MALIGNANT HISTIOCYTOMA .1. CLINICAL ASPECTS
SCAND J HAEMATOL, 16 (3), 209-217

Jonsson V, Videbek A, Axelsen NH, Harboe M (1976)
mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. I. Clinical aspects
16 (3), 209-17
DOI 10.1111/j.1600-0609.1976.tb01140.x, PubMed 179130

Saltvedt E, Harboe M (1976)
Binding of IgA to protein-A-containing staphylococci: relationship to subclasses
5 (10), 1103-8
DOI 10.1111/j.1365-3083.1976.tb00250.x, PubMed 1013646

SALTVEDT E, HARBOE M (1976)
BINDING OF IGA TO PROTEIN-A-CONTAINING STAPHYLOCOCCI - RELATIONSHIP TO SUBCLASSES
Scand. J. Immunol., 5 (10), 1103-1108

Publications 1975

CLOSS O, HARBOE M, WASSUM AM (1975)
CROSS-REACTIONS BETWEEN MYCOBACTERIA .1. CROSSED IMMUNOELECTROPHORESIS OF SOLUBLE-ANTIGENS OF MYCOBACTERIUM-LEPRAEMURIUM AND COMPARISON WITH BCG
Scand. J. Immunol. (2), 173-185

ERIKSEN J, HARBOE M, DEVERILL J (1975)
MONOCLONAL IGM WITH SPECIFIC ANTIBODY REACTIVITY AGAINST KLEBSIELLA SERO-TYPES 12 AND 13
ACTA PATH MICRO IM C, 83 (2), 106-111

Eskeland T, Harboe M (1975)
Common idiotypic antigenic determinants on monomeric (7S) and polymeric IgM from the same serum
4 (5-6), 583-90
DOI 10.1111/j.1365-3083.1975.tb02664.x, PubMed 52185

HARBOE M, DEVERILL J, ERIKSEN J (1975)
CAPSULAR SWELLING AND PASSIVE HEMAGGLUTINATION INDUCED BY MONOCLONAL IGM REACTING WITH ACID POLYSACCHARIDES OF KLEBSIELLA
ACTA PATH MICRO IM C, 83 (2), 97-105

Harboe M, Natvig JB (1975)
Medisinsk immunologi
Stiftelsen medisinsk immunologi, Oslo, 257 s.
BIBSYS 741136406, ISBN 82-90225-00-8

Harboe M, Natvig JB (1975)
Medisinsk immunologi
Universitetsforlaget, Oslo, 257 s.
BIBSYS 855005181, ISBN 82-00-02362-1

HARBOE M, SALTVEDT E, CLOSS O, OLSNES S (1975)
INTERACTIONS BETWEEN RICINUS AGGLUTININ AND HUMAN PLASMA-PROTEINS
Scand. J. Immunol. (2), 125-134

Lind I, Harboe M, Folling I (1975)
Protein A reactivity of two distinct groups of human monoclonal IgM
4 (8), 843-8
DOI 10.1111/j.1365-3083.1975.tb03726.x, PubMed 1215839

LIND I, HARBOE M, FOLLING I (1975)
PROTEIN-A REACTIVITY OF 2 DISTINCT GROUPS OF HUMAN MONOCLONAL-IGM
Scand. J. Immunol., 4 (8), 843-848
DOI 10.1111/j.1365-3083.1975.tb02695.x

Saltvedt E, Harboe M, Følling I, Olsnes S (1975)
Interactions between ricinus agglutinin and human IgM and IgG
4 (3), 287-94
DOI 10.1111/j.1365-3083.1975.tb02628.x, PubMed 1080291

Publications 1974

Axelsen NH, Harboe M, Closs O, Godal T (1974)
BCG antibody profiles in tuberculoid and lepromatous leprosy
9 (5), 952-8
DOI 10.1128/iai.9.5.952-958.1974, PubMed 4207518

Harboe M (1974)
[Immunological aspects of acquired hemolytic anemia]
94 (5), 312-5
PubMed 4544871

Harboe M (1974)
[The immunologists take a look at cell membrane]
94 (19), 1271-2
PubMed 4845302

Harboe M, Andersen PM, Foltmann B, Kay J, Kassell B (1974)
The activation of bovine pepsinogen. Sequence of the peptides released, identification of a pepsin inhibitor
249 (14), 4487-94
PubMed 4603017

Harboe M, Folling I (1974)
Complex formation between monoclonal IgM and albumin
3 (1), 51-60
DOI 10.1111/j.1365-3083.1974.tb01232.x, PubMed 4208200

Harboe M, Fölling I (1974)
Recognition of two distinct groups of human IgM and IgA based on different binding to staphylococci
3 (4), 471-82
DOI 10.1111/j.1365-3083.1974.tb01280.x, PubMed 4212304

Husby G, Natvig JB, Harboe M (1974)
The occurrence in sera with m-components of different proteins related to amyloid fibrils
3 (4), 391-6
DOI 10.1111/j.1365-3083.1974.tb01271.x, PubMed 4212436

Sletten K, Hannestad K, Harboe M (1974)
On the frequency of valine in position 2 of the V k3 subgroup
3 (2), 215-8
DOI 10.1111/j.1365-3083.1974.tb01250.x, PubMed 4207151

Sletten K, Hannestad K, Harboe M (1974)
Immunochemical detection of the VkIV subgroup
3 (2), 219-22
DOI 10.1111/j.1365-3083.1974.tb01251.x, PubMed 4856661

Publications 1973

Eskeland T, Harboe M (1973)
7S immunoglobulin M (IgM) from serum purified by anti-mu-chain immunoadsorbent: comparison of the reassociation properties of 7S IgM and various 19S IgM subunits
2 (5), 511-22
DOI 10.1111/j.1365-3083.1973.tb02057.x, PubMed 4204578

Harboe M (1973)
Immunoglobulins with special reference to cell-bound immunoglobulins
11 (2), 171-2
PubMed 4545243

Harboe M (1973)
Armauer Hansen--the man and his work
41 (4), 417-24
PubMed 4601451

Harboe M (1973)
[Scandinavian leprosy conference in Bergen. What do we know about leprosy and what do we do about it?]
88 (6), 186-9
PubMed 4778889

Harboe M, Foltmann B (1973)
The N-terminal amino acid sequence of bovine pepsin (EC 3.4.4.1) and the sequence overlapping the activation fragment
34 (2), 311-4
DOI 10.1016/0014-5793(73)80819-1, PubMed 4583851

Jakobsen A, Flatmark A, Harboe M (1973)
Rabbit anti rat lymphocyte serum: immunosuppression mediated by a pure IgM fraction
81 (5), 635-40
DOI 10.1111/j.1699-0463.1973.tb02254.x, PubMed 4209178

JAKOBSEN A, FLATMARK A, HARBOE M (1973)
RABBIT ANTI RAT LYMPHOCYTE-SERUM - IMMUNOSUPPRESSION MEDIATED BY A PURE IGM FRACTION
ACTA PATH MICRO IM B, B 81 (5), 635-640

Publications 1972

Harboe M (1972)
[Nobel prize for immunoglobulin research]
92 (34), 2363-5
PubMed 4568120

Harboe M (1972)
[Leprosy]
92 (11), 793-4
PubMed 5028902

Harboe M, Hannestad K, Sletten K (1972)
Oligoclonal macroglobulinaemia
1 (1), 13-26
DOI 10.1111/j.1365-3083.1972.tb03731.x, PubMed 4116376

Harboe M, Solheim BG (1972)
Formation of hybrid IgM subunits
1 (1), 63-73
DOI 10.1111/j.1365-3083.1972.tb03736.x, PubMed 4627538

Solheim BG, Harboe M (1972)
Reversible dissociation of reduced and alkylated IgM subunits to half subunits
9 (6), 623-34
DOI 10.1016/0019-2791(72)90248-0, PubMed 5041241

TORSVIK H, BOMAN H, BJERMANN I, HARBOE M, NORUM KR (1972)
BINDING OF LIPID DYES TO IMMUNOGLOBULINS
Clin. Chim. Acta, 42 (2), 433-435
DOI 10.1016/0009-8981(72)90108-8

Publications 1971

Harboe M (1971)
[Immunological diagnosis in hematological diseases]
91 (23), 1655-8
PubMed 4938861

Harboe M (1971)
Cold auto-agglutinins
20 (4), 289-305
DOI 10.1111/j.1423-0410.1971.tb00447.x, PubMed 4942296

Harboe M (1971)
Quantitation of human serum immunoglobulins
28 (3), 241
PubMed 5135091

Harboe M, Vandvik B (1971)
[Immunological diagnosis in hypergammaglobulinemia]
91 (23), 1641-7
PubMed 5110439

Natvig JB, Harboe M (1971)
[Clinical immunology]
91 (23), 1623-7
PubMed 4938859

Natvig JB, Harboe M, Fausa O, Tveit A (1971)
Family studies in individuals with selective absence of gamma-A-globulin
8 (2), 229-36
PubMed 4995563

Solheim BG, Harboe M, Deverill J (1971)
Individual antigenic specificity of human macroglobulins. II. Dependence of an antigenic determinant on the disulfide bond between the and kappa chains
8 (10), 939-49
PubMed 4114318

Stavem P, Harboe M (1971)
Acute erythroleukaemia in a patient treated with melphalan for the cold agglutinin syndrome
8 (5), 375-9
DOI 10.1111/j.1600-0609.1971.tb00887.x, PubMed 5289695

Stavem P, Harboe M (1971)
[Acute erythroleukemia in a melphalan-treated patient with cold agglutination syndrome]
86 (49), 1494
PubMed 5289909

Sudarsanam A, Grabosz J, Myklestad B, Myrvang B, Harboe M (1971)
Experimental Arthus reactions using the same antigen in soluble and corpuscular form
2 (4), 319-28
PubMed 4255853

Publications 1970

Hannestad K, Eriksen J, Christensen T, Harboe M (1970)
Multiple M-components in a single individual. I. The structural relationship of two serum gamma M kappa M-components as revealed by combining specificity and individual antigenic specificity
7 (11), 899-915
PubMed 4099674

Publications 1969

Harboe M (1969)
[The year's Jahre Prize winners: Hans Bennich, Docent, M. D., and S. Gunnar O. Johansson, Docent, M. D., Academic Hospital, Uppsala]
89 (11), 840
PubMed 4183801

Harboe M, Solheim BG, Deverill J (1969)
Individual antigenic specificity of human macroglobulins: Localization of antigenic determinants and their use to demonstrate formation of hybrid molecules after reduction and reassociation
129 (6), 1217-34
DOI 10.1084/jem.129.6.1217, PubMed 4977279

Harboe M, Torsvik H (1969)
Protein abnormalities in the cold haemagglutinin syndrome
6 (6), 416-26
DOI 10.1111/j.1600-0609.1969.tb01836.x, PubMed 4984643

Seip M, Harboe M, Cyvin K (1969)
Chronic autoimmune hemolytic anemia in childhood with cold antibodies, aplastic crises, and familial occurrence
58 (3), 275-80
DOI 10.1111/j.1651-2227.1969.tb04717.x, PubMed 5783414

Publications 1967

Harboe M (1967)
Absorption and control of specificity of antisera
100, 9
PubMed 4166858

Harboe M (1967)
[Genes and immunology]
87 (5), Suppl:470-4
PubMed 4167292

Publications 1966

Ceppellini R, Dray S, Fahey JL, Franklin EC, Fudenberg H, Gell PG, Goodman HC, Grubb R, Harboe M, Kirk RL, Oudin J, Ropartz C, Smithies O, Steinberg AG, Trnka Z (1966)
[Nomenclature of genetically determined characteristics of human immunoglobulins]
2 (3), 317-22
DOI 10.1007/BF00395948, PubMed 4168284

CEPPELLINI R, DRAY S, FAHEY JL, FRANKLIN EC, FUDENBERG H, GELL PG, GOODMAN HC, GRUBB R, HARBOE M, KIRK RL, OUDIN J, ROPARTZ C, SMITHIES O, STEINBERG AG, TRNKA Z (1966)
NOMENCLATURE OF GENETICALLY DETERMINED CHARACTERISTICS OF HUMAN IMMUNOGLOBULINS
HUMANGENETIK, 2 (3), 317

Harboe M (1966)
[We interview Erik Kåss, professor and physician at the Oslo Medical Society Rheumatism Hospital]
86 (6), 403-4
PubMed 5330298

Harboe M, Deverill J (1966)
Structural relationship between gamma-G- and gamma-M-globulin in man
445, 74-9
PubMed 4160695

Harboe M, Lind K (1966)
Light chain types of transiently occurring cold haemagglutinins
3 (4), 269-76
DOI 10.1111/j.1600-0609.1966.tb02371.x, PubMed 4958443

Harboe M, Pande H, Brandtzaeg P, Tveter KJ, Hjort PF (1966)
Synthesis of donor type gamma-G-globulin following thymus transplantation in hypo-gamma-globulinaemia with severe lymphocytopenia
3 (5), 351-74
DOI 10.1111/j.1600-0609.1966.tb02379.x, PubMed 4163435

Tönder O, Harboe M (1966)
Heterogeneity of cold haemagglutinins
11 (4), 361-8
PubMed 5924621

Publications 1965

AHO K, HARBOE M, SIEVERS K (1965)
RHEUMATOID FACTOR--AUTOSPECIFICITY OR ISOSPECIFICITY?
10, 225-7
DOI 10.1111/j.1423-0410.1965.tb04344.x, PubMed 14339234

Harboe M (1965)
Pepsin-splitting of gamma-M-globulins and high molecular weight antibodies
17, Suppl 84:232+
PubMed 4159557

Harboe M (1965)
Reaction of I-131 trace labeled cold agglutinin
124 (2), 491-8
DOI 10.1111/j.1749-6632.1965.tb18983.x, PubMed 4953945

HARBOE M (1965)
[NEW NOMENCLATURE FOR HUMAN IMMUNOGLOBULINS]
73, 108-9
PubMed 14252376

HARBOE M (1965)
[HEAVY CHAIN DISEASE]
73, 640-1
PubMed 14299151

HARBOE M (1965)
[INFERTILITY CAUSED BY IMMUNOLOGICAL FACTORS]
85, 308-9
PubMed 14305805

HARBOE M, DEVERILL J, GODAL HC (1965)
ANTIGENIC HETEROGENEITY OF WALDENSTROEM TYPE GAMMA-M-GLOBULINS
2, 137-47
PubMed 14341518

HARBOE M, RAU B, AHO K (1965)
PROPERTIES OF VARIOUS ANTI-GAMMA-GLOBULIN FACTORS IN HUMAN SERA
121 (4), 503-19
DOI 10.1084/jem.121.4.503, PubMed 14276773

Harboe M, van Furth R, Schubothe H, Lind K, Evans RS (1965)
Exclusive occurrence of K chains in isolated cold haemagglutinins
2 (3), 259-66
DOI 10.1111/j.1600-0609.1965.tb01303.x, PubMed 4158055

Heistö H, Harboe M, Godal HC (1965)
Warm haemolysins active against trypsinized red cells; occurrence, inheritance, and clinical significance
23, 787-9
DOI 10.1159/000384368, PubMed 4956292

Publications 1964

AHO K, HARBOE M, LEIKOLA J (1964)
STUDIES OF THE ANTIBODY NATURE OF THE RHEUMATOID FACTOR. REACTION OF THE RHEUMATOID FACTOR WITH SHEEP ERYTHROCYTES SENSITIZED WITH HUMAN ANTI-SHEEP CELL ANTIBODIES AND WITH O RH POSITIVE CELLS SENSITIZED WITH INCOMPLETE ANTI-RH ANTIBODIES
7 (4), 403-18
PubMed 14193154

HARBOE M (1964)
[STRUCTURE AND FUNCTION OF THE GAMMA GLOBULINS]
84, 16-22
PubMed 14101792

HARBOE M (1964)
[THYMUS: THE SUPREME IMMUNOLOGICAL ORGAN]
84, 46-51
PubMed 14101798

HARBOE M (1964)
INTERACTIONS BETWEEN 131-I TRACE-LABELLED COLD AGGLUTININ, COMPLEMENT AND RED CELLS
10, 339-46
DOI 10.1111/j.1365-2141.1964.tb00710.x, PubMed 14179488

HARBOE M, DEVERILL J (1964)
IMMUNOCHEMICAL PROPERTIES OF COLD HAEMAGGLUTININS
1, 223-37
DOI 10.1111/j.1600-0609.1964.tb00019.x, PubMed 14214902

Publications 1963

HARBOE M (1963)
SPECIFICITY OF RHEUMATOID FACTOR FOR GENETIC TYPES OF HUMAN GAMMA BLOBULIN
6, SUPPL 427-45
DOI 10.1002/art.1780060419, PubMed 14056855

HARBOE M, MUELLER-EBERHARD HJ, FUDENBERG H, POLLY MJ, MOLLISON PL (1963)
IDENTIFICATION OF THE COMPONENTS OF COMPLEMENT PARTICIPATING IN THE ANTIGLOBULIN REACTION
6 (4), 412-20
PubMed 14042906

OSTERLAND CK, HARBOE M, KUNKEL HG (1963)
Anti-gamma-globulin factors in human sera revealed by enzymatic splitting of anti-Rh antibodies
8, 133-52
DOI 10.1111/j.1423-0410.1963.tb03290.x, PubMed 13940587

Publications 1962

HARBOE M, OSTERLAND CK, KUNKEL HG (1962)
Localization of two genetic factors to different areas of gamma-globulin molecules
136 (3520), 979-80
DOI 10.1126/science.136.3520.979, PubMed 14036038

HARBOE M, OSTERLAND CK, MANNIK M, KUNKEL HG (1962)
Genetic characters of human gamma-globulins in myeloma proteins
116 (5), 719-38
DOI 10.1084/jem.116.5.719, PubMed 13952722

Publications 1961

HARBOE M (1961)
Specificity of a rheumatoid factor
7, 13-7
DOI 10.3109/rhe1.1961.7.issue-1-4.02, PubMed 13711447

HARBOE M (1961)
[The rheumatoid factor]
65, 216-7
PubMed 13711448

HARBOE M (1961)
Interactions of rheumatoid factor with immune precipitate containing antibody of human origin
20 (4), 363-8
DOI 10.1136/ard.20.4.363, PubMed 13904576

Harboe M (1961)
Tanker om kronisk polyarthrit: foredrag holdt på Norske kvinners sanitetsforenings kretsmøte for Oslo og Aker i september 1960
Oslo, 16 s.
BIBSYS 061886440

Harboe M (1961)
Studies on the gamma globulin (Gm) serum groups
Oslo University press, Oslo, 1 b. (flere pag.)
BIBSYS 962298522

HARBOE M, LUNDEVALL J (1961)
The application of the Gm system in paternity cases
6, 257-73
DOI 10.1111/j.1423-0410.1961.tb03162.x, PubMed 13711444

HARBOE M, REINSKOU T, HEISTO H, BJORNSTAD P (1961)
Studies on a serum with peculiar haemagglutinating properties
6, 409-28
DOI 10.1111/j.1423-0410.1961.tb03187.x, PubMed 13904575

JONSEN J, KASS E, HARBOE M (1961)
Complement and complement components in acquired hemolytic anemia with high titer cold antibodies
170, 725-9
DOI 10.1111/j.0954-6820.1961.tb00291.x, PubMed 14452388

Publications 1960

HARBOE M (1960)
Interactions between red cells coated with incomplete anti-D and rheumatoid sera
50, 383-97
DOI 10.1111/j.1699-0463.1960.tb01208.x, PubMed 13711445

HARBOE M (1960)
Relation between Gm types and hemagglutinating substances in rheumatoid sera
50, 89-105
DOI 10.1111/j.1699-0463.1960.tb01175.x, PubMed 13711446

Publications 1959

HARBOE M (1959)
A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry
11, 66-70
DOI 10.3109/00365515909060410, PubMed 13646603

HARBOE M (1959)
A new haemagglutinating substance in the Gm system, anti-Gm
183 (4673), 1468-9
DOI 10.1038/1831468a0, PubMed 13657175

HARBOE M (1959)
Quantitative studies on the hemagglutination inhibition reaction for determination of the Gm types
47, 199-208
DOI 10.1111/j.1699-0463.1959.tb04849.x, PubMed 14399692

HARBOE M (1959)
A new hemagglutinating substance in the Gm system, anti-Gmb
47, 191-8
DOI 10.1111/j.1699-0463.1959.tb04848.x, PubMed 14399693

HARBOE M, LUNDEVALL J (1959)
A new type in the Gm system
45 (4), 357-70
DOI 10.1111/j.1699-0463.1959.tb04721.x, PubMed 13660835

Publications 1957

HARBOE M (1957)
Lactic acid content in human venous blood during hypoxia at high altitude
40 (2-3), 248-53
DOI 10.1111/j.1748-1716.1957.tb01494.x, PubMed 13469531

HARBOE M (1957)
The influence of methemoglobin and storage upon the spectrophotometric determination of carbon monoxide in blood
9 (4), 317-21
PubMed 13495356

HARBOE M, VOGT LORENTZEN F (1957)
Ventilatory studies of the lungs during continuous pressure breathing
41 (1), 77-89
DOI 10.1111/j.1748-1716.1957.tb01511.x, PubMed 13497760